BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19479688)

  • 1. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
    Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
    Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eligibility, utilization, and costs in a California Medicaid lupus population.
    Nichol MB; Shi S; Knight TK; Wallace DJ; Weisman MH
    Arthritis Rheum; 2004 Dec; 51(6):996-1003. PubMed ID: 15593358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.
    Clarke AE; Petri MA; Manzi S; Isenberg DA; Gordon C; Senecal JL; St Pierre Y; Joseph L; Penrod J; Fortin PR; Sutcliffe N; Goulet JR; Choquette D; Grodzicky T; Danoff DS; Ho V; Esdaile JM
    J Rheumatol; 1999 Jul; 26(7):1500-11. PubMed ID: 10405937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of treatment of childhood-onset systemic lupus erythematosus.
    Brunner HI; Sherrard TM; Klein-Gitelman MS
    Arthritis Rheum; 2006 Apr; 55(2):184-8. PubMed ID: 16583393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period.
    Bell CF; Wu B; Huang SP; Rubin B; Averell CM; Chastek B; Hulbert EM
    BMC Health Serv Res; 2024 May; 24(1):691. PubMed ID: 38822336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of illness in patients with systemic lupus erythematosus hospitalized at academic medical centers.
    Ward MM
    J Rheumatol; 2005 Jan; 32(1):27-33. PubMed ID: 15630720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLE patients with renal damage incur higher health care costs.
    Clarke AE; Panopalis P; Petri M; Manzi S; Isenberg DA; Gordon C; Senécal JL; Joseph L; St Pierre Y; Li T
    Rheumatology (Oxford); 2008 Mar; 47(3):329-33. PubMed ID: 18238790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus.
    Lacaille D; Clarke AE; Bloch DA; Danoff D; Esdaile JM
    J Rheumatol; 1994 Mar; 21(3):448-53. PubMed ID: 8006887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing costs and improving outcomes in systemic lupus erythematosus: using regression trees to develop health policy.
    Clarke AE; Bloch DA; Danoff DS; Esdaile JM
    J Rheumatol; 1994 Dec; 21(12):2246-53. PubMed ID: 7699625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunological factors associated with lupus nephritis in patients from northwestern Colombia.
    Anaya JM; Uribe M; Pérez A; Sánchez JF; Pinto LF; Molina JF; Londoño MC; Cadavid ME; Matute G
    Biomedica; 2003 Sep; 23(3):293-300. PubMed ID: 14582332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of illness of chronic angina.
    Javitz HS; Ward MM; Watson JB; Jaana M
    Am J Manag Care; 2004 Oct; 10(11 Suppl):S358-69. PubMed ID: 15603245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs.
    Clarke AE; Esdaile JM; Bloch DA; Lacaille D; Danoff DS; Fries JF
    Arthritis Rheum; 1993 Nov; 36(11):1548-59. PubMed ID: 8240431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group.
    Clarke AE; Penrod J; St Pierre Y; Petri MA; Manzi S; Isenberg DA; Gordon C; Senecal JL; Fortin PR; Sutcliffe N; Goulet JR; Choquette D; Grodzicky T; Esdaile JM
    J Rheumatol; 2000 Nov; 27(11):2597-604. PubMed ID: 11093439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
    Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of osteoporosis-related fractures in Medicaid.
    Rousculp MD; Long SR; Wang S; Schoenfeld MJ; Meadows ES
    Value Health; 2007; 10(2):144-52. PubMed ID: 17391423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization and mortality of patients with systemic lupus erythematosus.
    Krishnan E
    J Rheumatol; 2006 Sep; 33(9):1770-4. PubMed ID: 16832848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urologic diseases in North America Project: trends in resource utilization for urinary tract infections in children.
    Freedman AL;
    J Urol; 2005 Mar; 173(3):949-54. PubMed ID: 15711347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs.
    Hankin CS; Cox L; Lang D; Levin A; Gross G; Eavy G; Meltzer E; Burgoyne D; Bronstone A; Wang Z
    J Allergy Clin Immunol; 2008 Jan; 121(1):227-32. PubMed ID: 18206509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of lupus.
    Clarke A
    Am J Manag Care; 2001 Oct; 7(16 Suppl):S496-501. PubMed ID: 11680782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical cost of chronic obstructive pulmonary disease in the U.S.A.
    Ward MM; Javitz HS; Smith WM; Bakst A
    Respir Med; 2000 Nov; 94(11):1123-9. PubMed ID: 11127502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.